PMC:7376974 / 87548-87781 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T419","span":{"begin":18,"end":26},"obj":"Body_part"},{"id":"T420","span":{"begin":43,"end":48},"obj":"Body_part"}],"attributes":[{"id":"A419","pred":"fma_id","subj":"T419","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A420","pred":"fma_id","subj":"T420","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ed activation and antibody production by B cells under anti-CD40/IL-4 stimulation. However, the molecular mechanism is still unknown.\nFigure 17 Use of fullerenol as co-adjuvant for vaccination. (a) The structure of fullerenol, red b"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1548","span":{"begin":60,"end":64},"obj":"Gene"},{"id":"1549","span":{"begin":65,"end":69},"obj":"Gene"},{"id":"1589","span":{"begin":152,"end":162},"obj":"Chemical"},{"id":"1590","span":{"begin":216,"end":226},"obj":"Chemical"}],"attributes":[{"id":"A1548","pred":"tao:has_database_id","subj":"1548","obj":"Gene:958"},{"id":"A1549","pred":"tao:has_database_id","subj":"1549","obj":"Gene:3565"},{"id":"A1589","pred":"tao:has_database_id","subj":"1589","obj":"MESH:C108127"},{"id":"A1590","pred":"tao:has_database_id","subj":"1590","obj":"MESH:C108127"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ed activation and antibody production by B cells under anti-CD40/IL-4 stimulation. However, the molecular mechanism is still unknown.\nFigure 17 Use of fullerenol as co-adjuvant for vaccination. (a) The structure of fullerenol, red b"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T808","span":{"begin":3,"end":13},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T809","span":{"begin":41,"end":48},"obj":"http://purl.obolibrary.org/obo/CL_0000236"},{"id":"T810","span":{"begin":196,"end":197},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"ed activation and antibody production by B cells under anti-CD40/IL-4 stimulation. However, the molecular mechanism is still unknown.\nFigure 17 Use of fullerenol as co-adjuvant for vaccination. (a) The structure of fullerenol, red b"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T20067","span":{"begin":65,"end":67},"obj":"Chemical"},{"id":"T48471","span":{"begin":169,"end":177},"obj":"Chemical"}],"attributes":[{"id":"A61532","pred":"chebi_id","subj":"T20067","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A9246","pred":"chebi_id","subj":"T20067","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A11813","pred":"chebi_id","subj":"T48471","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"}],"text":"ed activation and antibody production by B cells under anti-CD40/IL-4 stimulation. However, the molecular mechanism is still unknown.\nFigure 17 Use of fullerenol as co-adjuvant for vaccination. (a) The structure of fullerenol, red b"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T209","span":{"begin":18,"end":37},"obj":"http://purl.obolibrary.org/obo/GO_0002377"}],"text":"ed activation and antibody production by B cells under anti-CD40/IL-4 stimulation. However, the molecular mechanism is still unknown.\nFigure 17 Use of fullerenol as co-adjuvant for vaccination. (a) The structure of fullerenol, red b"}

{"project":"LitCovid-sentences","denotations":[{"id":"T532","span":{"begin":83,"end":133},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ed activation and antibody production by B cells under anti-CD40/IL-4 stimulation. However, the molecular mechanism is still unknown.\nFigure 17 Use of fullerenol as co-adjuvant for vaccination. (a) The structure of fullerenol, red b"}